Lesion Progression After Icon Treatment in Young Adults

Sponsor
DMG Dental Material Gesellschaft mbH (Industry)
Overall Status
Terminated
CT.gov ID
NCT01988337
Collaborator
(none)
56
1
2
42
1.3

Study Details

Study Description

Brief Summary

This is a three year single site clinical evaluation of a FDA approved (510(k):K100062) lesion penetrating resin used to infiltrate and hamper progression of proximal carious lesions. The purpose of this study is to compare lesion progression infiltrated with (Icon, Hamburg, Germany) to a similar sized lesion in the same patient treated with a placebo. The study is designed as a randomized, controlled, prospective clinical trial with a three year follow-up evaluation period.

The clinical site will enroll 150 subjects (in the age range of 19 years or older) with 2 study lesions. The patients will be evaluated at six time points over a period of 3 years. Lesion status and caries risk will be monitored at 6-month intervals, while radiographic evaluation will be conducted at 12-month intervals at 1-, 2- and 3-year recall visits.

Condition or Disease Intervention/Treatment Phase
  • Device: Resin infiltration
  • Other: Mock treatment
N/A

Detailed Description

Introduction Dental caries is the most widespread of all diseases. It causes destruction of tooth structure by dissolving the enamel on the outside of the tooth first and then progressing into the inside of the tooth. While it is possible to use traditional dental fillings to replace diseased tooth structure, it is far better to slow down or reverse the disease process so that no fillings are needed. One of the most difficult places to use preventive or non-surgical treatment is the contact area between teeth. Recently there is evolving interest in using composites to infiltrate enamel and dentin areas that have just begun to be destroyed by caries. The infiltration technique arrests the lesion progression by sealing the porous surface and restores the damage avoiding ongoing acidic damage of tooth structure.

Objective Assess the clinical efficacy s of using Icon to infiltrate initial lesions below the tooth surfaces that exist on the contact surfaces between posterior teeth as a means of stabilizing diseased tooth structure and arresting further lesion development.

Materials and Methods One hundred fifty volunteers (19+ years) with two early lesions in posterior teeth will be enrolled into a clinical trial to evaluate the clinical efficacy of infiltrating the lesions as compared to current watch-and-wait approaches that are combined with good oral hygiene and fluoride application. Each subject will have a treated lesion and a control lesion. Only small early lesions without clinical signs of surface cavitation will be selected. The control lesions will be stabilized through a normal preventive regimen, while the treatment lesions will be infiltrated with a resin. Lesion status will be monitored every six months by clinical examination and as well using annual radiographs.

Clinical Significance Infiltrating a caries lesion is a potential effective strategy to strengthen damaged tooth structure and to reduce caries progression without any surgical intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Prevention
Official Title:
Double Blind Randomized Controlled Clinical Trial of Lesion Progression After Treatment With Icon vs. Placebo in Caries Lesions in Young Adults Over 36 Months
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Jul 1, 2018
Actual Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Resin infiltration

One proximal caries lesion (split mouth design) per patient will be treated using the resin infiltrant "Icon" (DMG, Hamburg, Germany) according to manufactures´ instructions.

Device: Resin infiltration
The study is a split-mouth design. One tooth with a proximal caries lesion will randomly receive the infiltrating resin (Icon) while the other will receive a placebo, according to the manufactores´ instruction for Icon. In short, teeth will be isolated with a rubber dam and the tooth surface cleaned with non-fluoride prophylactic paste and pumice. The Icon material will be applied following the manufacturer's instructions and light cured, followed by polished using interproximal finishing/polishing strips (Sof Lex, 3M ESPE, St Paul, MN). Subjects will be given a letter to take to their local dentist asking them not to treat the selected lesions without informing the investigator first.
Other Names:
  • Icon (DMG, Germany), approximal resin infiltration kit
  • Sham Comparator: Mock treatment

    A second proximal caries lesion of each patient (split mouth design) will recieve a placebo treatment to mimic "resin infiltration".

    Other: Mock treatment
    For the mock treatment the procedure will be identical to the "Resin Infiltration" intervention, with the exception that a placebo will be used. Essentialy, syringes identical to the Icon materials will be supplied by DMG for the placebo procedure. The syringes will be filled with solutions having the same consistency and color as the Icon material.

    Outcome Measures

    Primary Outcome Measures

    1. Number of invasive interventions (fillings) [3 years]

      Dental examination.

    Secondary Outcome Measures

    1. Change in lesion size [6 months, 1 year, 2 years, 3 years]

      Radiographic analyses.

    Other Outcome Measures

    1. Influence of Icon treatment on clinical parameters [6 months, 1 year, 2 years, 3 years]

      Sensitivity to percussion, color change, sensitivity to periapical palpation, prolonged response to hot or cold.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Be age 19 years and older

    • Have at least two vital carious teeth with caries ranging from enamel to just into dentin.

    • If the lesion is not on a 3rd molar

    • If the lesion is not developmental.

    • If the lesion is not cavitated

    • Be a regular dental attendee able to return for assessments

    • Be in good medical health and able to tolerate the dental procedure

    • Have no chronic periodontitis which could compromise tooth retention.

    • Have normal salivary function.

    • Have normal bone levels

    • No lingering cold sensitivity

    • No periapical sensitivity

    • No sensitivity to percussion

    Exclusion Criteria:
    • Do not meet the inclusion criteria

    • Are not able to tolerate the time required for the study

    • There is a history of an adverse reaction to any materials used in the study

    • They are irregular dental attendees

    • They maintain an unacceptable standard of oral hygiene.

    • They have chronic periodontitis

    • There is severe salivary gland dysfunction or reduced salivary flow is observed

    • They are unable to return for recall appointments

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama Birmingham Alabama United States 35294

    Sponsors and Collaborators

    • DMG Dental Material Gesellschaft mbH

    Investigators

    • Principal Investigator: Nate O. Lawson, Birmingham, Alabama 35294; US

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    DMG Dental Material Gesellschaft mbH
    ClinicalTrials.gov Identifier:
    NCT01988337
    Other Study ID Numbers:
    • TOPIC36
    First Posted:
    Nov 20, 2013
    Last Update Posted:
    Nov 16, 2018
    Last Verified:
    Nov 1, 2018
    Keywords provided by DMG Dental Material Gesellschaft mbH
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 16, 2018